Nepal

Date established	1994
Contact details	Sunaulo Parivar Nepal GPO Box No. 11254 Char Khal Adda Dillibazar Kathmandu Nepal Telephone: + 97 714 47 7739 Email: msi@msinepal.enet.com.np
Services offered	Family planning; abortion; health screening; HIV/STIs; maternal health; post abortion care; refugees/IDPs; social marketing; young people
Number of clinics	50
Outreach / mobile services	Yes
Social marketing products and brands	Condoms: Jodi Gold Contraceptive pill: Feminyl
Major donors	European Community; International Planned Parenthood Federation (IPPF)

Click on red marker for clinic/programme information.
Click on map to close marker balloon.

Click on satelite for photo view,
and hybrid for photo and map view.

Highlights

one of the leading reproductive health providers in Nepal – in 2006 alone, Sunaulo Parivar Nepal carried out 44% of all sterilisations and 70% of all abortions in the country
the successful reproductive health training centre which is fully accredited by the Government of Nepal. As well as providing training for Sunaulo Parivar Nepal’s team members the centre also attracts clinical trainees from the public sector and other NGOs
recently launched Feminyl – an oral contraceptive pill brand

Future plans

have a network of more than 60 clinics offering the full range of sexual and reproductive health services by the end of 2008
increase the number of longer term methods (i.e. IUDs and contraceptive injections) provided through the social marketing programme

Key statistics for Nepal
Source: UNFPA State of world population 2007
Total population (millions) (2007)	28.2
Average population growth rate (%) (2005 - 2010)	1.9
Projected population (millions) (2050)	51.2
Life expectancy (M / F)	62.8 / 63.9
Total fertility rate (2007)	3.32
% contraceptive prevalence: any method	39
% contraceptive prevalence: modern methods	35
Births per 1,000 women aged 15-19	102
% births with skills attendants	11
Maternal mortality ratio (per 100,000 live births)	740
Infant mortality total per 1,000 live births	56
Under 5 mortality (M / F)	71 / 75
HIV prevalence rate (%) (15-49) M / F	0.8 / 0.2
Health expenditure public (% of GNP)	1.5